TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DRDRACULA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

DRDRACULA

ST13

US500000097664428

Classe

44

Pedido

97664428

Registro

8243369

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

44

Atualização mais recente

05/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

44

Data de depósito

05/11/2022

Data de registro

05/05/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/05/2026

Última transação

05/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/02/2025

Primeiro uso no comércio

01/02/2025

Código do desenho

4

Tipo de titular

16

Localização do titular

Miami, FL, US

Examinador

KRAVTSOFF, ELENA V N

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Constant Click, LLC

Representantes

Constant Click, LLC

Classificação técnica

Classes Nice

Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 44

Antibody testing for medical diagnostic or treatment purposes; Collection and preservation of human blood; Consulting services in the fields of diagnostic medical testing and nutrition; Consulting services in the fields of health and nutrition; Drug use screening services; Drug use testing services; Genetic testing for medical purposes; Health care services offered through a network of health care providers on a contract basis; Health care services, namely, blood testing; Health assessment services, namely, providing metabolic assessment profiles (MAP) to clients obtained by using a portable metabolic measurement system in the nature of a unique, heart-rate based overview of their own metabolism in order to assist in reaching weight loss, sports performance, health, fitness, and wellness-related goals; Managed health care services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical assistance consultancy provided by doctors and other specialized medical personnel; Medical clinic services; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of blood testing; Medical services; Medical testing for fitness evaluation; Medical testing of urine, blood, hair follicles and breath; Phlebotomy services; Pregnancy testing services; Providing an interactive website featuring information and links relating to healthy living and weight loss; Providing an on-line computer database featuring information regarding health and nutrition; Providing health care information by telephone and the internet; Providing information about dietary supplements and nutrition; Providing information about health, wellness and nutrition via a website; Providing nutritional information about drinks; Providing on-line information, news and commentary in the field of health and wellness relating to blood testing; Providing personalized healthcare and medical information in the nature of blood testing; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Tissue typing services; Virus testing for medical diagnostic or treatment purposes; Web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; Health care services, namely, providing a database in the field of blood testing information and featuring inputting and collection of data and information all for treatment and diagnostic purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

44 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/05/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/05/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

15/04/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

15/04/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

15/04/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

15/04/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

15/04/2026

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

15/04/2026

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

29/12/2025

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

29/12/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/10/2025

GNRT

NON-FINAL ACTION E-MAILED

01/10/2025

CNRT

SU - NON-FINAL ACTION - WRITTEN

01/10/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

21/09/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

21/09/2025

IUAF

USE AMENDMENT FILED

29/04/2025

EISU

TEAS STATEMENT OF USE RECEIVED

29/04/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

29/10/2024

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

22/09/2024

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

04/06/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/05/2024

PUBO

PUBLISHED FOR OPPOSITION

14/05/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

08/04/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/04/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

08/04/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/04/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/03/2024

ALIE

ASSIGNED TO LIE

11/03/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/10/2023

NREV

NOTICE OF REVIVAL - E-MAILED

23/10/2023

PETG

PETITION TO REVIVE-GRANTED

23/10/2023

PROA

TEAS PETITION TO REVIVE RECEIVED

23/10/2023

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

24/08/2023

MAB2

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

24/08/2023

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

24/08/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

27/04/2023

GNRT

NON-FINAL ACTION E-MAILED

27/04/2023

CNRT

NON-FINAL ACTION WRITTEN

27/04/2023

DOCK

ASSIGNED TO EXAMINER

20/04/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

23/11/2022

NWAP

NEW APPLICATION ENTERED

09/11/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DRDRACULA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.